戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 t Th cell lineages, including Th17, Th9, and induced regulatory T cells.
2 ed methylation of FOXP3 CpG sites in antigen-induced regulatory T cells.
3 d to allow conversion of CD4(+) T cells into induced regulatory T cells.
4 s to the retinoic acid expansion of TGF-beta-induced regulatory T cells.
5 ion into the effector subsets Th1, Th17, and induced regulatory T cells.
6 he pro-inflammatory phenotype of Aspergillus-induced regulatory T-cells.
7 tibody levels, but the latter preferentially induced regulatory T cells and in general downregulated
8 tes the differentiation of anti-inflammatory induced regulatory T cells and proinflammatory Th1 cells
9 ligation of OX40 inhibited the production of induced regulatory T cells and the T(H)17 subset of help
10 nversion of conventional CD4(+) T cells into induced regulatory T cells and with the expression of IF
11 nversely, liver DCs with low levels of lipid induced regulatory T cells, anergy to cancer, and oral t
12                  These data suggest that pDC-induced regulatory T cells are dependent on downstream s
13          The differentiation and function of induced regulatory T cells, by contrast, was independent
14 oreactive T cell activation, and can promote induced regulatory T cell development.
15 injected exosomes accumulated in the MLN and induced regulatory T cell differentiation to promote car
16 nsion of P. gingivalis-specific Th cells and induced regulatory T cells does not depend on mucosal LC
17 it the inopportune induction of peripherally induced regulatory T cells during immune responses again
18 d antigen specificity of both endogenous and induced regulatory T cells during these interactions.
19 induction of donor-reactive forkhead box P3+-induced regulatory T cells (Foxp3(+) iTreg) in mice trea
20 omotes the differentiation of Th1, Th17, and induced regulatory T cells, implying that under certain
21 ndent manner and inhibited the generation of induced regulatory T cells in vitro.
22  the differentiation of Ag-specific Foxp3(+) induced regulatory T cells in vivo.
23 ls acquired an induced regulatory phenotype (induced regulatory T cell) in the infarcted myocardium a
24                                              Induced regulatory T cells (iT(reg) cells) can be genera
25 initiated and CD4(+) T cells became Foxp3(+) induced regulatory T cells (iT(reg) cells).
26  converts naive T cells into IL-35-producing induced regulatory T cells (iTr35 cells).
27       Sirt-1-deficient T cells also promoted induced regulatory T cell (iTreg) differentiation and in
28 rated that galectin-9 is highly expressed by induced regulatory T cells (iTreg) and was crucial for t
29           However, Foxp3 expression in these induced regulatory T cells (iTreg) is unstable, raising
30                           These Foxp3 cells (induced regulatory T cells (iTreg)) share functional and
31                          These Foxp3+ cells (induced regulatory T cells (iTreg)) share functional and
32 roperties and therapeutic potential of these induced regulatory T cells (iTreg), we examined their im
33 tiation into T helper 1 (Th1), Th2, Th17 and induced regulatory T cells (iTreg).
34 the feasibility and efficacy of using murine-induced regulatory T cells (iTregs) for the induction of
35 ressed TIM-4 leads to increased induction of induced regulatory T cells (iTregs) from naive CD4(+) T
36 l (in this issue) reporting an enrichment in induced regulatory T cells (iTregs) in normal pregnancy
37  promote differentiation of Foxp3-expressing induced regulatory T cells (iTregs), high levels of Ag h
38 ubsets in response to Ag, including Foxp3(+) induced regulatory T cells (iTregs).
39  early therapeutic group, the frequencies of induced regulatory T cells (iTregs: CD4(+)CD25(-)Fopx3(+
40                                             "Induced" regulatory T cells (iTregs) are nonredundant an
41 ells but also into fully functional Foxp3(+) induced regulatory T cell-like gamma/delta T cells.
42 l, follicular helper T cell (T(FH) cell) and induced regulatory T cell lineages.
43 ells) and discrimination between natural and induced regulatory T cells (nT(reg) and iT(reg) cells).
44 xample, Janus kinase (JAK) inhibitors), IL-2-induced regulatory T cells or advanced combination thera
45 t naive T cells can also differentiate into 'induced' regulatory T cells or inflammatory T cells that
46 e (IDO) and was associated with expansion of induced regulatory T cells, particularly at the site of
47                                   Peripheral induced regulatory T cells (pTreg cells) play a central
48 estine, RORyt is coexpressed in peripherally induced regulatory T cells (pTregs) together with Foxp3,
49 d not upregulate costimulatory molecules and induced regulatory T cells rather than effector T cells.
50                             Type II monocyte-induced regulatory T cells specific for a foreign antige
51 matinib therapy activated CD8(+) T cells and induced regulatory T cell (T(reg) cell) apoptosis within
52 CD4(+) T cells and depletion of peripherally induced regulatory T cells through Fcgamma receptor sign
53                                   Such tumor-induced regulatory T cells (TMTregs) arose both from pre
54 ike transcription factor, TIEG1, in TGF-beta-induced regulatory T cell (Treg) development.
55                                 Pretreatment induced regulatory T cell (Treg) expansion persisting 1
56 nity to the suppressive activity of helminth-induced regulatory T cells (Tregs) or Th2 cells.
57  In addition to early developmental links to induced regulatory T cells (Tregs) reflected in the shar
58 brogated the suppressive function of therapy-induced regulatory T cells (Tregs).
59 d box protein 3 (FOXP3) CpG sites in antigen-induced regulatory T cells were significantly different
60  cells: TGF-beta induces Foxp3 and generates induced regulatory T cells, whereas IL-6 inhibits TGF-be
61  in CD103(+) DCs inhibited the generation of induced regulatory T cells while promoting Th1 cell deve